FridayNov 18, 2011 10:05 am

TiVUS, Inc. (TIVU) Becomes Independent Media Content Provider; Launches Ku-band Hotel Satellite Feed

Today before the opening bell, TiVUS, Inc. told investors it has signed an agreement with a leading digital media services company to secure broadcast rights agreements for all needed cable channels and premium content providers. TiVUS' HD content is now delivered via its new private Ku-band satellite feed of hotel HD IPTV television content. Due to competitive reasons, the partner's name was withheld. "I am pleased to announce this important technology partnership," stated Shiva Prakash, TiVUS' chief executive officer. "This new partnership replaces our former agreement with EchoStar®, who announced in August it was to electively begin shutting down its…

Continue Reading

ThursdayNov 17, 2011 6:48 pm

China Sunergy Co., Ltd. (CSUN) Reports Third Quarter of 2011 Financial Results

China Sunergy Co., Ltd. reported a large year-over-year increase in sales for the third quarter of 2011, as the company benefited from higher customer demand for solar cells and modules. China Sunergy reported sales of $145.8 million for the quarter ending 9/30/2011. This level of sales represented a 16% increase over the same quarter in 2010, and a 1% sequential increase from the second quarter of 2011. China Sunergy also saw a 30% sequential increase in solar module shipments in the most recent quarter, with the company shipping 116.2 megawatts. This was the highest quarterly level of shipments in the…

Continue Reading

ThursdayNov 17, 2011 4:44 pm

Genesis Biopharma, Inc. (GNBP) Names Dr. Steven Rosenberg Inventor of Cancer Treatment Therapy to Scientific and Medical Advisory Board

Genesis Biopharma, Inc., a biotechnology company developing targeted cancer immunotherapies, announced today the appointment of Dr. Steven Rosenberg, Chief of the Surgery Branch at the National Cancer Institute, to their Scientific and Medical Advisory Board. Dr. Rosenberg pioneered the development of immunotherapy as a successful treatment for select patients with advanced cancer. Genesis Biopharma is currently working on the development and commercialization of treatments for various cancers, including a product known as Contego, which is a ready-to-infuse autologous cell therapy that uses tumor infiltrating lymphocytes for the treatment of patients with Stage IV metastatic melanoma. Genesis Biopharma has licensed rights…

Continue Reading

ThursdayNov 17, 2011 2:09 pm

Small Cap Voice Audio Interview with President and CEO of Tootie Pie Company (TOOT) is Now Available

SmallCapVoice.com, Inc. announced today that a new audio interview with Tootie Pie Company, Inc., a premium baker and seller of high-quality, handmade pies, is now available. The interview can be heard at http://smallcapvoice.com/blog/11-16-11-smallcapvoice-interview-with-tootie-pie-company-otcqb-toot Tootie Pie Company, Inc. reported on Wednesday, November 16th that quarterly revenue jumped 100%, to $630,601 for the quarter ending September 2011, versus $315,907 for September 2010. SmallCapVoice is a recognized corporate investor relations firm, with clients nationwide, known for its ability to help emerging growth companies build a following among retail and institutional investors. SmallCapVoice utilizes its stock newsletter to feature its daily stock picks and…

Continue Reading

ThursdayNov 17, 2011 2:02 pm

Small Cap Voice Audio Interview with President and CEO of Stakool Inc. (STKO) is Now Available

SmallCapVoice.com, Inc. announced today that a new audio interview Stakool Inc., a Florida-based corporation and its wholly-owned subsidiary, Anthus Life Corp., is now available. The interview can be heard at http://smallcapvoice.com/blog/11-14-11-smallcapvoice-interview-with-anthus-life-corp-otcbb-stko. The interview features the insights of the Company spokesperson and seven time Olympic medalist Shannon Miller along with the Company president and CEO Peter Hellwig. Peter Hellwig, President & CEO of Stakool Inc., stated, “We are very happy to share our story with our shareholders and the investing public. This interview is just a small part of our overall goal and campaign to increase our Company’s visibility with potential…

Continue Reading

ThursdayNov 17, 2011 1:51 pm

Beacon Equity Research: Marc Faber on Gold, Stocks & QE3

As the global financial crisis accelerates in the fourth quarter following revised economic data revealing a high probability of another recession in Europe and the United States (see BER article of Nov. 7) on the horizon, the ever-entertaining publisher of the Gloom Boom Doom Report Marc Faber stated Wednesday that he’s convinced that governments across the globe will print money to prevent a collapse of the financial system. Japan, the UK and EU continue to relentlessly debase their respective currencies in a fight to retain a piece of shrinking global demand, simultaneously reducing crushing debt obligations in real terms priced…

Continue Reading

ThursdayNov 17, 2011 1:39 pm

Drop in Unemployment Applications Suggests Hiring May Improve

Another indication that the jobs picture may be getting ready to improve came Thursday with the Labor Department’s announcement that weekly unemployment benefit applications dropped by 5,000 to a seasonally adjusted 388,000. It was the lowest level since early April, and the fourth decline in five weeks. The four-week average dropped below 400,000 for the first time in seven months, to 396,750. The numbers suggest an easing in layoffs, which could be setting the stage for an increase in hiring. Applications need a consistent drop below 375,000 for sustained job growth. The last time that number was seen was in…

Continue Reading

ThursdayNov 17, 2011 1:36 pm

SANUWAVE Health Inc. (SNWV) Presents Positive Phase 3 Clinical Data to Large Federal Healthcare Audience

SANUWAVE Health Inc., an emerging regenerativee medicine company, today announced that positive data from its phase III clinical trial of dermaPACE® for the treatment of diabetic foot ulcers was the subject of a Continuing Medical Education (CME) accredited presentation at Desert Foot 2011: The 8th Annual High Risk Diabetic Foot Conference, honoring Federal Service Healthcare Providers, in Phoenix, Ariz. The company’s PACE® technology delivers high-energy acoustic pressure waves to accelerate inflammatory response to speed up the body’s natural healing process. Robert Frykberg, DPM, MPH, chairman of Desert Foot 2011, a surgeon at the Carl T. Hayden Veterans Affairs Medical Center…

Continue Reading

ThursdayNov 17, 2011 1:31 pm

Strategic American Oil Corp. (SGCA) Reports Positive Income from Operations; Anticipates Continued Increases in Production, Cash Flow and Assets

Strategic American Oil Corp. today reported its financial results for the fiscal fourth quarter ended July 31, 2011. Revenues totaled $1.92 million as compared to $1.49 million for the previous three quarters combined. Income from Operations for Q4 was a positive $3,118 as compared to a loss of $8.8 million in the three previous quarters combined. The company also told investors that the "going concern" note has been removed from its audit opinion contained in its recently filed Form 10-K for the year ended July 31, 2011. The annual filing confirms that the Company has increased revenues, cash flow, assets,…

Continue Reading

ThursdayNov 17, 2011 1:02 pm

Marina Biotech (MRNA) Given Patent in China for Its Intranasal Insulin Delivery Formulation

Marina Biotech Inc. is a biotechnology company focused on the development and commercialization of oligonucleotide-based therapeutics. The company's innovative therapeutics utilize multiple mechanisms of action, including RNA interference and messenger RNA translational blocking. The company reported today that China's State Intellectual Property Office has issued a Notification of Granting Patent Rights for PRC 200680047851. This patent covers pharmaceutical formulations for intranasal delivery of insulin, and uses of the formulation to treat diseases associated with inappropriate insulin levels. The president of CEO of Marina Biotech, J. Michael French, said, “We believe that the intranasal assets from our predecessor company, Nastech Pharmaceutical,…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered